Search

everythinglearnresearchcommunity

for

Search:↓

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Ellagic acid may help prevent hair loss caused by testosterone in rats.

CD101 is highly effective in treating dermatophytosis in guinea pigs.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Topical gabapentin was safe and effective for treating scalp symptoms and promoting hair regrowth in cicatricial alopecias.

The treatment for alopecia areata with diphenylcyclopropenone was unsuccessful.

Baricitinib helps treat severe hair loss in people over 65.

Baricitinib is effective and safe for treating severe alopecia areata.

A woman's hair grew back with baricitinib treatment, but she developed a temporary hairy tongue that was treated with regular tongue brushing.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Etanercept may not prevent alopecia areata from coming back.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

The treatment increased total hair count but wasn't significantly better than placebo.

N-acetylcysteine effectively treats trichotillomania.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.